-+ 0.00%
-+ 0.00%
-+ 0.00%

United Therapeutics CEO Chair Martine Rothblatt disposes of 9,500 shares for $4.81 million

PUBT·08/14/2026 20:48:44
Listen to the news
United Therapeutics CEO Chair Martine Rothblatt disposes of 9,500 shares for $4.81 million
  • United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares on Aug. 13, 2026.
  • A family trust sold 9,500 shares the same day at about $500.58 per share, in multiple trades.
  • The trust’s beneficial ownership in common stock ended the day at 324,443 shares.
  • The trust reported 141,910 stock options remaining.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001106578-26-000120), on August 14, 2026, and is solely responsible for the information contained therein.